Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.47 |
| ▸ | LTA4H | P09960 | 2/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | GMNN | O75496 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Catechol SCHEMBL10388895 | 0.98 | MEN1 (0.52) | TSHRCYP3A4TP53MAPK1MAPT | |
| Catechol SCHEMBL8451493 | 0.98 | MEN1 (0.52) | TSHRCYP3A4TP53MAPK1MAPT | |
| Catechol SCHEMBL1401742 | 0.93 | TSHR (0.50) | TSHRCYP3A4TP53MAPK1MAPT | |
| Salicyl Alcohol SCHEMBL9280827 | 0.85 | TSHR (0.45) | TSHRCYP3A4TP53MAPK1MAPT | |
| Phenol SCHEMBL27291071 | 0.85 | NR5A1 (0.55) | TSHRCYP3A4TP53MAPK1MAPT | |
| Catechol SCHEMBL28964364 | 0.84 | LMNA (0.50) | TSHRCYP3A4TP53MAPTMEN1 | |
| Catechol SCHEMBL10905366 | 0.84 | HTR1A (0.46) | CYP3A4HTTLMNALTA4HHPGD | |
| SCHEMBL31651139 | 0.84 | HTR1A (0.47) | TSHRCYP3A4TP53MAPTMEN1 | |
| SCHEMBL20237256 | 0.84 | BID (0.49) | TSHRCYP3A4TP53MAPTMEN1 | |
| Octane SCHEMBL27871796 | 0.84 | ALDH1A1 (0.56) | TSHRCYP3A4TP53MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117964812-A | Alkoxy magnesium particles, and corresponding catalyst solid component and catalyst system thereof | 中国石油化工股份有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-117964813-A | Solid catalyst component and catalyst system for olefin polymerization and preparation method thereof | 中国石油化工股份有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-117964814-A | Ziegler-Natta solid catalyst component, catalyst and application thereof | 中国石油化工股份有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-117964812-A | Alkoxy magnesium particles, and corresponding catalyst solid component and catalyst system thereof | 中国石油化工股份有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-117964813-A | Solid catalyst component and catalyst system for olefin polymerization and preparation method thereof | 中国石油化工股份有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-117964814-A | Ziegler-Natta solid catalyst component, catalyst and application thereof | 中国石油化工股份有限公司 | 2024-05-03 | — | — | CN | disclosed |
| US-9382245-B2 | Compounds and methods for treating HIV infections | YALE UNIVERSITY (US) | 2016-07-05 | — | — | US | disclosed |
| US-20150105351-A1 | COMPOUNDS AND METHODS FOR TREATING HIV INFECTIONS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150105351-A1 | COMPOUNDS AND METHODS FOR TREATING HIV INFECTIONS | POLM, POLRMT, DHFR | TSHR 4583/4885CYP3A4 614/4885TP53 3417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.